Liver cancer
liver cancer
Epidemiology:
Hepatocellular carcinoma (HCC), the most common form of liver cancer, is a significant global health issue. It is the sixth most frequently diagnosed cancer and the fourth leading cause of cancer-related death worldwide, accounting for over 700,000 deaths annually¹.
Liver cancer often develops in people with pre-existing chronic liver diseases, especially cirrhosis. The most common underlying causes include chronic infection with hepatitis B virus (HBV) and hepatitis C virus (HCV), excessive alcohol consumption, and non-alcoholic fatty liver disease (NAFLD), which is often linked to obesity and type 2 diabetes².
Spontaneous remission (SR) of any type of cancer is an extremely rare phenomenon and its frequency is difficult to estimate in medical practice. It has been reported that SR may account for less than 2% of all reported cases of SR of neoplasms³. Irrespective of cancer type or histopathology, SR is a very rarely reported phenomenon within the medical profession. Because cases of SR tend to be reported only when the “regression is both dramatic and durable [and] less dramatic regressions, for many reasons, tend to get overlooked and are almost never reported”⁴. It is therefore difficult to estimate the frequency with which liver cancer undergoes SR as part of its natural history. By definition, SR is the complete or partial disappearance or regression of cancer without any treatment that could be credited with its remission. Due to its rarity and the tendency for only the most "dramatic and durable" cases to be reported, the true frequency of SR in liver cancer is likely underestimated.
Clinical Characteristics:
To date, there have been 100 reported cases of SR of either primary or metastatic liver cancer. There are several clinical trends that may be observed among these cases. The patients’ age at the time of regression ranges from 14 to 92 years with a peak incidence of 60-70 years of age. Males showed much higher rates (2:1) of SR of CRC, with all cases of SR from rectal cancers occurring in males. See table 1 below for further information.
Histological and Imaging Characteristics
The predominant histological diagnosis is hepatocellular carcinoma (HCC), with tumors exhibiting varying levels of differentiation, including well-differentiated, moderately differentiated, and poorly differentiated forms. Other tumor types were not included in this analysis.
Imaging findings consistently show the presence of one or more heterogeneous masses in the liver, most commonly located in the right hepatic lobe. Common laboratory findings include elevated serum levels of the tumor markers alpha-fetoprotein (AFP) and PIVKA-II, as well as elevated liver enzymes such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST).
Proposed Contributing Mechanisms
The following factors are proposed to contribute to the spontaneous regression of liver cancer, with the number of cases citing each mechanism detailed below:
- Vascular/Ischemia (36 cases): This is the most frequently proposed mechanism. It is believed that a disturbance in the tumor's blood supply, caused by factors such as portal vein thrombosis, hemorrhage-induced ischemia, or arterial embolization, leads to tumor infarction and necrosis, which results in subsequent regression.
- Immune Response (20 cases): This mechanism suggests that the patient's own immune system is responsible for the regression. Evidence for this includes histological findings of lymphocyte infiltration, macrophage overactivation, and an overall anti-tumoral immune reaction.
- Other/Systemic Factors (16 cases): Various other systemic factors are mentioned, including hormonal changes(postpartum), the use of specific herbal medicines, vitamin K administration, radiation therapy, systemic viral clearance, and hemodynamic changes associated with dialysis.
- No Reported Mechanism (30 cases): A significant portion of the cases is described as having no definitive cause for their regression, with some being explicitly labeled as "truly spontaneous" or "unspecified."
Site and extent of regressions
In the 102 cases of spontaneous regression (SR) of liver cancer, a majority of patients experienced complete regression of their tumors, with all evidence of the lesion disappearing on follow-up imaging. Several cases, however, showed a partial regression, with the tumors shrinking significantly but not fully resolving.
The site and extent of the regression varied:
- Primary Tumor Only (62 cases): The regression was confined to the primary hepatic lesion.
- Metastases Only (11 cases): The SR was observed exclusively in metastatic sites, such as lung nodules or enlarged lymph nodes, with no change to the primary liver tumor.
- Primary and Metastases (29 cases): In these cases, both the primary liver tumor and its metastases regressed simultaneously.
The follow-up period for these patients ranged from months to over a decade, with many surviving for several years after the documented SR event.
Table 1: CRC SR Cases and Clinical Characteristics
Author–year | Age/sex | Primary site | Remission site | Proposed mechanisms | Follow-up |
|---|---|---|---|---|---|
65-year old male; 1-week history of abdominal pain; anorexia and 12-lb weight loss over two months prior; history of hypertension, diabetes, hypercholesterolemia and obesity; blood pressure 120/60 | right hepatic lobe | over period of a few months, symptoms improved and tumour showed radiological evidence of spontaneous involution coupled with decrees in AFP levels, meeting criteria for spontaneous resolution; follow-up CT 14 weeks after initial diagnosis showed significant interval reduction in size of mass with associated atrophy of right hepatic lobe; occlusion of right portal veing at 14 weeks was still present, but main portal vein thrombus and periaortic lymphadenopathy had resolved; CT scan 28 weeks after initial diagnosis showed persistent right portal vein occlusion and small hypodensity in posterior segment of right hepatic lobe; CT scan 14 months from initial diagnosis showed small irregular hypodensity in posterior segment of right hepatic lobe with no area of abnormality anywhere else; ultrasound 2 years after initial diagnosis showed no liver lesions and AFP level remained below 10 ug/L | speculation that local ischemia due to rapid tumour growth resulted in intra tumoural bleeding and/or hemorrhagic necrosis (based on cases in literature) | over period of a few months, symptoms improved and tumour showed radiological evidence of spontaneous involution coupled with decrees in AFP levels, meeting criteria for spontaneous resolution; follow-up CT 14 weeks after initial diagnosis showed significant interval reduction in size of mass with associated atrophy of right hepatic lobe; occlusion of right portal veing at 14 weeks was still present, but main portal vein thrombus and periaortic lymphadenopathy had resolved; CT scan 28 weeks after initial diagnosis showed persistent right portal vein occlusion and small hypodensity in posterior segment of right hepatic lobe; CT scan 14 months from initial diagnosis showed small irregular hypodensity in posterior segment of right hepatic lobe with no area of abnormality anywhere else; ultrasound 2 years after initial diagnosis showed no liver lesions and AFP level remained below 10 ug/L | |
54-year old African-American male; chronic hepatitis C infection; medical history included coronary artery disease, hypertension, dyslipidemia, peripheral neuropathy, chronic lumbago; meds include metoprolol, albuterol inhaler, oxycodone, hydrochlorothiazide, nitroglycerine, aspirin, gabapentin, doxazosin, ezetimibe, cyclobenzaprine | right hepatic lobe | admitted for pneumonia 22 months after 2- months follow up at which time it was discovered that HCC was in remission; continues to be in remission 4 years after initial diagnosis | None reported | admitted for pneumonia 22 months after 2- months follow up at which time it was discovered that HCC was in remission; continues to be in remission 4 years after initial diagnosis | |
63-year old Caucasian man with hepatitis C and Child's class A cirrhosis presented with mental status changes related to hepatic encephalopathy, demonstrated asterixis and presence of ascites; reported recent fatigue and anorexia; medical history included post-traumatic stress disorder and thrombocytopenia | right hepatic lobe | CT two months after diagnosis showed that known mass had decreased in size and was now predominately cystic; multiphase CT showed that tumour was no uniformly hypodense and cystic on all four phases, without arterial enhancement or portal venous phase washout, no new masses detected; CT 10 months after initial presentation showed continued reduction in size, was non-enhancing and remained cystic with no additional masses | proposed vascular etiology related to hemorrhage-induced ischaemia, possible that acute onset of haemodynamic instability had altered the tumoural blood supply, resulting in tumour infarction and necrosis | CT two months after diagnosis showed that known mass had decreased in size and was now predominately cystic; multiphase CT showed that tumour was no uniformly hypodense and cystic on all four phases, without arterial enhancement or portal venous phase washout, no new masses detected; CT 10 months after initial presentation showed continued reduction in size, was non-enhancing and remained cystic with no additional masses | |
74-year old woman presented with back pain and blood in urine; history of alcohol misuse, hypertension, cholecystectomy and tubal ligation | inferior left hepatic lobe | 2 months later a CT scan showed a dramatic reduction in number and size of lesions and liver tests had returned to normal; subsequent CT scans over the next 19 months continued to show regression or resolution of all lesions | no specific mechanism for this case offered | 2 months later a CT scan showed a dramatic reduction in number and size of lesions and liver tests had returned to normal; subsequent CT scans over the next 19 months continued to show regression or resolution of all lesions | |
54-year old female; past medical history includes liver cirrhosis associated with hepatitis B virus | right hepatic lobe | refused any therapy, was admitted 4 years after initial diagnosis for nausea, vomiting and diffuse abdominal pain; physical exam, lab findings, ultrasound and CT showed no evidence of lesion, just vague wedge-shaped area with low density in hepatic dome | cirrhotic changes observed on imaging study could have caused ischemia, contributing to spontaneous regression of tumour | refused any therapy, was admitted 4 years after initial diagnosis for nausea, vomiting and diffuse abdominal pain; physical exam, lab findings, ultrasound and CT showed no evidence of lesion, just vague wedge-shaped area with low density in hepatic dome | |
57-year old male with HBV-related cirrhosis; diagnosed as HBeAg-positive CHB and on entecavir therapy | segment 6 of liver | within 5 weeks after diagnosis, AFP level declined to 50 ng/mL prior to surgery, surgical specimen showed complete necrosis of tumour rimmed by inflamed fibrous capsule, background of mass showed HBV-related mixed micro and macronodular cirrhosis with infiltration of lymphoplasma cells and focal granulomatous inflammation | host immune response based on lymphoplasma cell infiltration with granulomatous inflammation | within 5 weeks after diagnosis, AFP level declined to 50 ng/mL prior to surgery, surgical specimen showed complete necrosis of tumour rimmed by inflamed fibrous capsule, background of mass showed HBV-related mixed micro and macronodular cirrhosis with infiltration of lymphoplasma cells and focal granulomatous inflammation | |
64-year-old male, previously undergone right lobectomy of liver due to HCC in October 2006, chronic hepatitis B virus carrier | liver + lung & adrenal mets | patient returned for follow-up in May 2009, no change; in September 2009, symptoms had improved and chest regiograph showed that all metastatic nodules had disappeared and serium AFP levels had decreased, regression of HCC tumour observed; CT scan in December 2009 showed that all metastatic nodules in lung and lesions in adrenal glands and lymph nodes had disappeared; follow-up CT scans showed no recurrent lesions and chest radiograph showed no metastatic lesions, serum AFP and PIVKA II levels within normal; patient is alive with no symptoms as of May 2013 | None reported | patient returned for follow-up in May 2009, no change; in September 2009, symptoms had improved and chest regiograph showed that all metastatic nodules had disappeared and serium AFP levels had decreased, regression of HCC tumour observed; CT scan in December 2009 showed that all metastatic nodules in lung and lesions in adrenal glands and lymph nodes had disappeared; follow-up CT scans showed no recurrent lesions and chest radiograph showed no metastatic lesions, serum AFP and PIVKA II levels within normal; patient is alive with no symptoms as of May 2013 | |
67-year-old man, obese, the patient had begun a diet three years earlier and had succeeded in reducing his weight by approximately 5 kg. Past medical history of hypertension at 48 years of age and diabetes mellitus and hepatic dysfunction due to hepatic steatosis at 55 years of age, with no history of transfusion. He had no history of alcohol consumption or smoking and no family history of note. | liver | The patient’s postoperative course was favorable, and he was discharged from the hospital 11 days after undergoing surgery. He has since visited the hospital regularly for over three years, with no signs of recurrence. | spontaneous regression due to the presence of both arterial and portal vein thrombi. | The patient’s postoperative course was favorable, and he was discharged from the hospital 11 days after undergoing surgery. He has since visited the hospital regularly for over three years, with no signs of recurrence. | |
56-year-old woman with liver cirrhosis due to HCV infection | Liver | Six months later, the tumour had been diminished, its dimensions were 3x2.5 cm. In August of the same year, the tumour was surgically removed with the segments V and VIII of the liver. The pathology report was of a hepatocellular carcinoma moderately differentiated of 2.8 vs 2.6 cm, margins were clear of tumour, there was imporightant necrosis around the tumour, and it also has macronodular cirrhosis with intense activity (Figure 3). The patient did not receive adjuvant treatment, and after 25 months of surgery she is doing well, with no evidence of tumour recurrence at CT scan and the AFP level is still within the normal range. | disturbance of the blood supply on the peripheral side | Six months later, the tumour had been diminished, its dimensions were 3x2.5 cm. In August of the same year, the tumour was surgically removed with the segments V and VIII of the liver. The pathology report was of a hepatocellular carcinoma moderately differentiated of 2.8 vs 2.6 cm, margins were clear of tumour, there was imporightant necrosis around the tumour, and it also has macronodular cirrhosis with intense activity (Figure 3). The patient did not receive adjuvant treatment, and after 25 months of surgery she is doing well, with no evidence of tumour recurrence at CT scan and the AFP level is still within the normal range. | |
80-year-old man, He drank 350 mL of beer every day but had no history of the use of herbal medicines | liver | Because the patient wanted to undergo an operation for gallbladder stones, preoperative evaluation for cholecystectomy was carried out. In December 2000, just before the operation, a CT scan showed that Lipiodol was accumulated in the tumour in S4 and that the cystic mass in S6 was decreased in size spontaneously, down to 57 mm×44 mm. Celiac ARTeriogram one year later from the first visit, showed that the previous tumour stain in S4 disappeared. The super mesenteric ARTeriogram demonstrated 2 tumour stains; one was in S6, which was previously hypovascular, and the other was in S8. Transarterial embolization with gel foam was repeated but the tumour resisted therapy, with rapid invasion and intrahepatic metastasis | local ischemia, leading to intratumoural bleeding or hemorrhagic necrosis | Because the patient wanted to undergo an operation for gallbladder stones, preoperative evaluation for cholecystectomy was carried out. In December 2000, just before the operation, a CT scan showed that Lipiodol was accumulated in the tumour in S4 and that the cystic mass in S6 was decreased in size spontaneously, down to 57 mm×44 mm. Celiac ARTeriogram one year later from the first visit, showed that the previous tumour stain in S4 disappeared. The super mesenteric ARTeriogram demonstrated 2 tumour stains; one was in S6, which was previously hypovascular, and the other was in S8. Transarterial embolization with gel foam was repeated but the tumour resisted therapy, with rapid invasion and intrahepatic metastasis | |
74-year old Caucasian male, non-smoker and consumed 2 units of alcohol daily. | liver | After six months from diagnosis, the patient attended for reevaluation of his disease. Over that time he had suffered a cerebrovascular accident (CVA) with ensuing partial hemiparesis. CT scan revealed that the pulmonary lesion had disappeared, whereas the suspicious hepatic lesion and the lesion anterior to the pericardium had significantly decreased in size. | None reported | After six months from diagnosis, the patient attended for reevaluation of his disease. Over that time he had suffered a cerebrovascular accident (CVA) with ensuing partial hemiparesis. CT scan revealed that the pulmonary lesion had disappeared, whereas the suspicious hepatic lesion and the lesion anterior to the pericardium had significantly decreased in size. | |
85-year-old man with liver cirrhosis due to HCV and diabetes mellitus. no history of alcohol drinking or blood transfusion. He did not smoke and was not taking any medicine, but was under intermediate-acting insulin (12 U/d) injection. He had undergone surgery for prostate hypertrophy 3 years before the present admission. | liver | CE-CT, 5 months after starting vitamin K, demonstrated that the tumour sizes were remarkably decreased and the diameter of the main tumour was 5.5 cm. US demonstrated that the tumour regressed and the margin of the tumour became obscure | blood shortage induced by rapid tumour growth or regression due to vitamin K administration | CE-CT, 5 months after starting vitamin K, demonstrated that the tumour sizes were remarkably decreased and the diameter of the main tumour was 5.5 cm. US demonstrated that the tumour regressed and the margin of the tumour became obscure | |
69-year-old man with chronic hepatitis C, diagnosed in 2001 and a gastric ulcer. He had no known history of a blood transfusion or medication such as anticoagulant drugs and vitamin K. He was, however, a heavy drinker. | liver | 2 months after the first US, and a new US showed a 5.1 ¥ 5.0-cm liver tumour in S4. The tumour showed a mosaic pattern with a halo. 9 months after, Dynamic CT was performed revealed the previous tumour in S4 to have decreased to 2.0cm in diameter, but it was not enhanced | possibly related to a disturbance of the blood supply on the peripheral side, such as the formation of a thick capsule | 2 months after the first US, and a new US showed a 5.1 ¥ 5.0-cm liver tumour in S4. The tumour showed a mosaic pattern with a halo. 9 months after, Dynamic CT was performed revealed the previous tumour in S4 to have decreased to 2.0cm in diameter, but it was not enhanced | |
A 73-year-old man with hepatitis B virus (HBV) infection. He consumed 25 g of alcohol daily for 50 years and had also smoked 10 cigarettes per day for 50 years. | liver | Anterior lobectomy of the liver was planned. However, 1 month after the initial diagnosis, a plain MRI disclosed a regression of the tumour to 6 mm, and the AFP serum level decreased to 87.8 ng/ml. He had stopped alcohol consumption and smoking after the HCC diagnosis. Six months after the initial diagnosis, follow-up MRI showed no mass | ischemia secondary to angiography | Anterior lobectomy of the liver was planned. However, 1 month after the initial diagnosis, a plain MRI disclosed a regression of the tumour to 6 mm, and the AFP serum level decreased to 87.8 ng/ml. He had stopped alcohol consumption and smoking after the HCC diagnosis. Six months after the initial diagnosis, follow-up MRI showed no mass | |
77-year-old man with alcoholic liver cirrhosis, Child-Pugh class B. No history of hypertension, diabetes mellitus, and atherosclerosis. He had been a regular drinker, consuming approximately 120 g/day of alcohol every day for 50 years. He had smoked 20 cigarettes per day for 50 years. | liver | One months after the diagnosis, tumour markers decreased, the mass in S8 decreased to 30 mm and became completely necrotic on CT ARTeriography. The 15-mm mass in the S8-7 diminished to 10 mm and was described as an enhanced lesion | disrupatiention of the feeding artery associated with angiography or arterial thrombosis | One months after the diagnosis, tumour markers decreased, the mass in S8 decreased to 30 mm and became completely necrotic on CT ARTeriography. The 15-mm mass in the S8-7 diminished to 10 mm and was described as an enhanced lesion | |
75-year-old man with chronic hepatitis C and diabetes mellitus. no history of alcohol abuse, smoking, blood transfusion, or steroid intake. He took ursodeoxycholic acid for a liver function disorder pointed out 20 years ago. | liver with lung mets | At 3 months after the initial medical examination, the serum tumour markers had decreased markedly. After 9 months, ab- dominal CT revealed that the liver mass had markedly decreased in size and the multiple nodules in the bilateral lungs had disappeared. After 13 months, HCC of 5 cm in size was detected in segment 5/6 of the liver. At 15 months after the first visit, because there was no further decrease in tumour size in the imaging studies and an increase in tumour markers, TACE was done with a second one 13 months after. | None reported | At 3 months after the initial medical examination, the serum tumour markers had decreased markedly. After 9 months, ab- dominal CT revealed that the liver mass had markedly decreased in size and the multiple nodules in the bilateral lungs had disappeared. After 13 months, HCC of 5 cm in size was detected in segment 5/6 of the liver. At 15 months after the first visit, because there was no further decrease in tumour size in the imaging studies and an increase in tumour markers, TACE was done with a second one 13 months after. | |
79 year old man, active liver cirrhosis (non-HAV, non-HNV), he used prednisone + azathiopine for 3 months. All treatment was stopped in march. | liver | 5 months later a US should tumour size reduciton. A CT/US control after 1 month showed further reduction. 3 years later the tumour disappeared. | Severe hemorrhagic shock related | 5 months later a US should tumour size reduciton. A CT/US control after 1 month showed further reduction. 3 years later the tumour disappeared. | |
65-year-old Japanese man, no notable family history. Hisotry of DM and chronic hepatitis secondary to daily alcohol usage for 40 year. | liver | A 1 year later follow up CT showed the hepatic mass to have deceased to 7cm in diameter. An arterial porightogram demonstrated a complete obstruction of the right posterior branch of the portal vein. Biopsy of the especimen retrieved from the lobectomy, demonstrated a necrotic core of the mass with a thick capsule. | Disturbance in both the portal venous and hepatic artery flow | A 1 year later follow up CT showed the hepatic mass to have deceased to 7cm in diameter. An arterial porightogram demonstrated a complete obstruction of the right posterior branch of the portal vein. Biopsy of the especimen retrieved from the lobectomy, demonstrated a necrotic core of the mass with a thick capsule. | |
50-year-old man there was no previous history of heavy alcohol intake, operations, or blood transfusions. | liver | no info | overactivation of CD163+ macrophages | no info | |
56-year-old man, 15-year history of chronic liver disease related to HBV | liver | one months after the second hospital discharge, no masses were found on abdominal US | both the spontaneous HBsAg seroconversion and the HCC regression could be trig- gered by restoration or reinforcement of virus-specific T-cell immunity | one months after the second hospital discharge, no masses were found on abdominal US | |
71-year-old woman with history of chronic HCV for ten years. No history of alcohol abuse, smoking, blood transfusion, or steroid intake. | liver | Histological findingsdemonstrate capsular damage or rupture associated with arterial injury prior to surgery. | Local hepatic factor | Histological findingsdemonstrate capsular damage or rupture associated with arterial injury prior to surgery. | |
71-year-old woman, HCV chronic infection of 8 years without any special treatment. no past medical and family history of note and did not smoke or drink | liver | Three months later, a repeat abdominal ultrasound demonstrated a shrinkage of the hepatic lesion and thrombosis of the feeding artery. CT scan showed only vague signs of a hepatic tumour, and the serum AFP level was in the normal range | Tumour infarction secondary to vascular occlusion | Three months later, a repeat abdominal ultrasound demonstrated a shrinkage of the hepatic lesion and thrombosis of the feeding artery. CT scan showed only vague signs of a hepatic tumour, and the serum AFP level was in the normal range | |
79-year-old male patient, hypertension and chronic heart failure. He had a history of alcohol abuse. Child-Pugh A | liver | Preoperative MRI revealed a faint high-intensity tumor in T1WI, similar to the results 2 months prior. However, T2WI and DWI showed a lesion with higher intensity than that seen 2 months prior . These findings were suggestive of HCC with spontaneous regression. | no info | Preoperative MRI revealed a faint high-intensity tumor in T1WI, similar to the results 2 months prior. However, T2WI and DWI showed a lesion with higher intensity than that seen 2 months prior . These findings were suggestive of HCC with spontaneous regression. | |
61-year-old male, full-time engineer, type 2 diabetes mellitus and hypertension, and was also being worked up for aortic valve replacement for severe aortic stenosis, he was on metformin, acute myeloid leukemiaodipine, aspirin, ramipril, insulin, and simvastatin | liver | Follow-up CT five months later showed continued regression of tumour and lymphadenopathy; however, the AFP level was margin- ally higher at 19 | tumour tissue-specific immune-mediated mechanism | Follow-up CT five months later showed continued regression of tumour and lymphadenopathy; however, the AFP level was margin- ally higher at 19 | |
Case 1: 64-year-old man. Past history of heavy drinking. | liver | Three months later, clinical condition improved and AFP returned to normal values. CT showed regression of all liver tumours, with a centimetric cyst appearance of all except one. Histological study of the specimen (obtained from surgery) confirmed a well-differentiated encapsulated HCC with the presence of marked inflammation, necrosis with calcifications, and fibrosis. | immune activation inducing specific anti-tumoural reaction by T-cell cytotoxicity. | Three months later, clinical condition improved and AFP returned to normal values. CT showed regression of all liver tumours, with a centimetric cyst appearance of all except one. Histological study of the specimen (obtained from surgery) confirmed a well-differentiated encapsulated HCC with the presence of marked inflammation, necrosis with calcifications, and fibrosis. | |
case 2: 70-year-old woman, history of alcoholism | liver | Ultrasonography 10 months after the diagnosis showed diffuse liver heterogeneity, and 5 months later only one remaining 47 mm tumour in the posterior inferior segment. At that time serum alpha-fetoprotein was decreased. She was admitted to hospital 18 months after the initial diagnosis for massive digestive bleeding related to rupture of oesophageal varices. CT showed ascitis, regression of all liver tumours, with a cystic appearance of al | Ultrasonography 10 months after the diagnosis showed diffuse liver heterogeneity, and 5 months later only one remaining 47 mm tumour in the posterior inferior segment. At that time serum alpha-fetoprotein was decreased. She was admitted to hospital 18 months after the initial diagnosis for massive digestive bleeding related to rupture of oesophageal varices. CT showed ascitis, regression of all liver tumours, with a cystic appearance of al | ||
74-year-old male, history of well-controlled type 2 diabetes mellitus and hypertension. There was no evidence of hepatitis, liver cirrhosis, or hepatocellular cancer in his family members | liver | Six months after taking the decoction; the tumor shrank from 10 cm to about 4 cm in diameter. 3 months later CT showed nearly complete shrinkage of the tumor in the left hepatic lobe; only a small residual tumor remained at the top of the left lobe. AFP returned within normal range | Six months after taking the decoction; the tumor shrank from 10 cm to about 4 cm in diameter. 3 months later CT showed nearly complete shrinkage of the tumor in the left hepatic lobe; only a small residual tumor remained at the top of the left lobe. AFP returned within normal range | ||
65-year-old Caucasian man with a his- tory of non-alcoholic steatohepatitis. | liver | After six months a CT scan showed a marked reduction in size of the major lesion from 9.5 cm to 3.3 cm and a substantial reduc- tion of the number of the other smaller lesions. Six months later fur- ther improvement of the radiological findings was observed: the main nodular lesion was 2.5cm and only three satellite lesions unchanged in size were observed One year later the patient was symptom- free and a CT scan showed the main lesion reduced to 2.2 cm and only one satellite nodule. | possible mechanisms include the use of herbal medicine (AA), ischaemic and inflammatory processes | After six months a CT scan showed a marked reduction in size of the major lesion from 9.5 cm to 3.3 cm and a substantial reduc- tion of the number of the other smaller lesions. Six months later fur- ther improvement of the radiological findings was observed: the main nodular lesion was 2.5cm and only three satellite lesions unchanged in size were observed One year later the patient was symptom- free and a CT scan showed the main lesion reduced to 2.2 cm and only one satellite nodule. | |
72-year-old male, who consumed more than 80 g of alcohol per day, history of hypertension, under pharmacological treatment, and chronic alcoholic liver disease | liver | 3 months later, MRI was repeated for restating showing a decrease in the size of the nodule (14 × 16 mm), which was well-defined and hypointense in T1, and heterogeneous with poor peripheral contrast uptake in the late venous phase. An additional histological study was also performed, showing necrotic tissue and abundant macrophages. The histological study conducted on the surgical specimen showed a hyalinised nodular lesion mea- suring 16 × 20 × 8 mm, with no signs of malignancy | 3 months later, MRI was repeated for restating showing a decrease in the size of the nodule (14 × 16 mm), which was well-defined and hypointense in T1, and heterogeneous with poor peripheral contrast uptake in the late venous phase. An additional histological study was also performed, showing necrotic tissue and abundant macrophages. The histological study conducted on the surgical specimen showed a hyalinised nodular lesion mea- suring 16 × 20 × 8 mm, with no signs of malignancy | ||
77-year-old woman, hepatitis C was diagnosed at the age of 69, cholecystectomy for gallstones at the age of 30, partial thyroidectomy for multinodular goiter at the age of 35 and hysterectomy for uterine le-year-old maleioma at the age of 47 | Liver | she was waiting for a partial right liver resection and 3 months after the onset of symptoms, the pain gradually abated and the analgesics could be discontinued. A control CT scan showed a reduction in size of the focal liver lesion to 2.8 cm. Laboratory tests showed normalization of AFP levels. Another CT scan demonstrated a further reduction in size of the focal lesion whose diameter was now 1.8 cm. | strong immunologic reaction against tumour antigens. | she was waiting for a partial right liver resection and 3 months after the onset of symptoms, the pain gradually abated and the analgesics could be discontinued. A control CT scan showed a reduction in size of the focal liver lesion to 2.8 cm. Laboratory tests showed normalization of AFP levels. Another CT scan demonstrated a further reduction in size of the focal lesion whose diameter was now 1.8 cm. | |
66-year-old man, chronic hepatitis C virus and chronic gastritis, no history of alcohol consumption or blood transfusions | Liver with multiple metastases | the patient began to improve clinically and recover his appetite. The sternoclavicular lesions gradually disappeared and the abdominal pain remitted. Disappearance of the intraabdominal (confirmed by CT) and cutaneous masses in the sternoclavicular region 16 months after resection of the HCC | possible immune mechanism | the patient began to improve clinically and recover his appetite. The sternoclavicular lesions gradually disappeared and the abdominal pain remitted. Disappearance of the intraabdominal (confirmed by CT) and cutaneous masses in the sternoclavicular region 16 months after resection of the HCC | |
A 52-years-old man | Liver | At repeat laparotomy 14 months after initial diagnosis, intraoperative ultrasound failed to disclose a hepatic mass, and multiple biopsies stowed no evidence of malignancy. | At repeat laparotomy 14 months after initial diagnosis, intraoperative ultrasound failed to disclose a hepatic mass, and multiple biopsies stowed no evidence of malignancy. | ||
73-year-old man, dialysis three times a week due to diabetic renal failure. | liver with lung mets | Five months after hepatectomy, the multiple lung metastases had completely regressed and the AFP and PIVKAII levels were both normalized | Extended posterior segmentectomy | Five months after hepatectomy, the multiple lung metastases had completely regressed and the AFP and PIVKAII levels were both normalized | |
60-year-old man | colon + liver mets | Nine months after surgery, the patient stated that he was feeling well, and reported a weight gain of 5 kg. The CT of the abdomen showed a remarkable regression of liver tumors in both lobes | extensive tumor necrosis | Nine months after surgery, the patient stated that he was feeling well, and reported a weight gain of 5 kg. The CT of the abdomen showed a remarkable regression of liver tumors in both lobes | |
73-year-old man, use of digitalis for treatment of transient dysrhythmia. | Liver | coeliac angiography was performed 15 months later; no tumour was seen. | coeliac angiography was performed 15 months later; no tumour was seen. | ||
77-year-old male, type 2 diabetes mellitus, He had smoked 20 cigarettes per day since adolescence | Liver + lungs mets | Four months after the diagnosis, Radiological studies revealed a wedge-shaped low-density area (indicating necrosis of HCC) in the liver and the disappearance of multiple nodular lesions in both lungs. Tumor markers returned to normal values | Four months after the diagnosis, Radiological studies revealed a wedge-shaped low-density area (indicating necrosis of HCC) in the liver and the disappearance of multiple nodular lesions in both lungs. Tumor markers returned to normal values | ||
72-year-old male, He had smoked 10 cigarettes per day for 50 years. | liver | 2 years later, a CT revealed a small ellipatientic cystic region in the anterior segment and a reduced size of heterogeneous low-density area with enhanced circumference in the posterior segment of the liver. PIVKA-II had markedly decreased to the normal range but AFP was double the original value | 2 years later, a CT revealed a small ellipatientic cystic region in the anterior segment and a reduced size of heterogeneous low-density area with enhanced circumference in the posterior segment of the liver. PIVKA-II had markedly decreased to the normal range but AFP was double the original value | ||
A 79-year-old man, chronic hepatitis C and liver cirrhosis | Liver + lungs mets | Six months later, ab- dominal dynamic enhanced MRI indicated disappear- ance of the tumor in the S8 region and plain chest CT showed that the nodular lesions had disappeared. AFP and PIVKA-II levels had decreased to normal values, as of 6 months later, as the primary lesion and lung metastases regressed. | Regression could have been attributable to the antitumor effects of P. linteus. | Six months later, ab- dominal dynamic enhanced MRI indicated disappear- ance of the tumor in the S8 region and plain chest CT showed that the nodular lesions had disappeared. AFP and PIVKA-II levels had decreased to normal values, as of 6 months later, as the primary lesion and lung metastases regressed. | |
65-year-old man, one episode of duodenal bulb ulcer 35 years earlier | Liver | 6 months later, early-phase contrast-enhanced CT showed a high-density tumor in S7, The diameter of the tumor was 3–4 cm and the tumor volume had decreased remarkably compared to the previous CT. 2 years after diagnosis, serum concentration of PIVKA-II had decreased dramatically. In addition, a CT scan confirmed that the tumor had completely disappeared | 6 months later, early-phase contrast-enhanced CT showed a high-density tumor in S7, The diameter of the tumor was 3–4 cm and the tumor volume had decreased remarkably compared to the previous CT. 2 years after diagnosis, serum concentration of PIVKA-II had decreased dramatically. In addition, a CT scan confirmed that the tumor had completely disappeared | ||
70-year-old man, history of heavy alcohol intake, liver cirrhosis with esophageal varices | Liver | One more later, CT showed viable tumor volume shrinkage, and the AFP level decreased | One more later, CT showed viable tumor volume shrinkage, and the AFP level decreased | ||
75-year-old man, postive HCV | liver with lung mets | 4 months after TAE, follow-up CT and AFP did not show any relapse of HC. 4 months after discontinueatin chemotherapy, the multiple lung nodules had clearly decreased in number and in size | 4 months after TAE, follow-up CT and AFP did not show any relapse of HC. 4 months after discontinueatin chemotherapy, the multiple lung nodules had clearly decreased in number and in size | ||
67-year-old man, multiple liver tumors, social drinker | liver | 1 year after relapse, AFP levels decreased, CT showed shrinkage of the primary liver mass and the disappearance of the pleural effusion and ascites | 1 year after relapse, AFP levels decreased, CT showed shrinkage of the primary liver mass and the disappearance of the pleural effusion and ascites | ||
67-year-old man, HCC diagnosis | liver with lung mets | Six months after CAMs his performance status had improved and the AFP level had decreased. The multiple lung nodules and liver tumors had clearly disappeared. | Six months after CAMs his performance status had improved and the AFP level had decreased. The multiple lung nodules and liver tumors had clearly disappeared. | ||
44-year-old male, heavy drinker for the past 5 years | Liver + lungs mets | 5 months later the patient felt better than before, the AFP level decreased, CT showed a small tumour | intratumoral event | 5 months later the patient felt better than before, the AFP level decreased, CT showed a small tumour | |
63 year-old man, HBV infection for the past 15 years | liver | Three months later the liver was not palpable and AFP return to normal values. One year later a CT showed that the previous tumour had schrunk to 5cm. 1 year later, US demonstrated that the previous compression of the IVC by the original tumour had disappeared. 3 years later, the original tumour had become smaller. | intratumoral event | Three months later the liver was not palpable and AFP return to normal values. One year later a CT showed that the previous tumour had schrunk to 5cm. 1 year later, US demonstrated that the previous compression of the IVC by the original tumour had disappeared. 3 years later, the original tumour had become smaller. | |
53-year-old man, history of HBV | liver | Microscopic examination showed no malignant cells | inflammatory reaction | Microscopic examination showed no malignant cells | |
77-year-old with 10 year history of HBV infection and liver cirrhosis | liver | A second abdominal CT scan was thus performed 7 months later no hypervascular nodule could be detected. A 5-mm non-enhancing lesion was present at the location of the initial nodule. After 30- months follow-up the patient is well and recent US examinations have been unable to detect initial liver lesion recurrence. | tumor necrosis | A second abdominal CT scan was thus performed 7 months later no hypervascular nodule could be detected. A 5-mm non-enhancing lesion was present at the location of the initial nodule. After 30- months follow-up the patient is well and recent US examinations have been unable to detect initial liver lesion recurrence. | |
62-year-old man, history of chronic HBV with liver cirrhosis for 10 years. Stroke | liver | 2 years after admission, AFP normalized and the size of the tumor had reduced to 1.5 cm, by the end of that year it went almost undetectable. | Hypoxic condition that leads to tumor necrosis | 2 years after admission, AFP normalized and the size of the tumor had reduced to 1.5 cm, by the end of that year it went almost undetectable. | |
76-year-old man with liver cirrhosis caused by the hepatitis C virus | liver | On abdominal CT in October 1998, no tumors were noted, except for a small lesion that was probably a scar, and the PIVKA-II level was normalized | immunological mechanism. | On abdominal CT in October 1998, no tumors were noted, except for a small lesion that was probably a scar, and the PIVKA-II level was normalized | |
92-year-old Japanese woman with cryptogenic chronic liver disease for about 10 years. Schistosoma japonica infection | liver | On follow up in July 2011, a sudden return of AFP to normal values. A dynamic CT in August 2011 showed complete disappearance of HCC and marked fatty change of the liver | immune response | On follow up in July 2011, a sudden return of AFP to normal values. A dynamic CT in August 2011 showed complete disappearance of HCC and marked fatty change of the liver | |
65-year-old Korean man, 100 g of alcohol per day for 30 years | liver + skull mets | Ten months after radiation therapy, the follow-up CT revealed a marked reduction in the size of the hepatic mass and a reduction in the number of nodules. In addition, a fol- low up whole body bone scan also showed an absence of the previous hot uptakes of the ribs, sternum and a reduced uptake of the skull lesion | first, a rapid expansion of the hepatic and skull masses induced necrosis of the tumors or a portal vein occlusion. Second, radiation therapy toward the skull mass induced a delayed abscopal phe- noumenon that reduced the remote original hepatic masses. Third, the ingestion of Phellinus linteus and/or radiation therapy may have affected the regression pro- cess simultaneously or separately by immunological modulation due to some unknown mechanisms. | Ten months after radiation therapy, the follow-up CT revealed a marked reduction in the size of the hepatic mass and a reduction in the number of nodules. In addition, a fol- low up whole body bone scan also showed an absence of the previous hot uptakes of the ribs, sternum and a reduced uptake of the skull lesion | |
86-year-old woman with cirrhosis caused by hepatitis C virus | liver | A repeat ultrasound study after 4 months showed that the tumor had decreased in size to less than 4 cm in diameter and that her serum des-g-carboxy prothrombin level had decreased from 678 mAU/ml to 27 mAU/ml. Histologic evaluation of a percutaneous liver biopsy showed extensive necrosis with only a few residual tumor cells. | infarction of tumor tissue because of thrombosis or vasculitis in small ARTeries that supply blood to the tumor. Another possible mechanism is immunologic activation | A repeat ultrasound study after 4 months showed that the tumor had decreased in size to less than 4 cm in diameter and that her serum des-g-carboxy prothrombin level had decreased from 678 mAU/ml to 27 mAU/ml. Histologic evaluation of a percutaneous liver biopsy showed extensive necrosis with only a few residual tumor cells. | |
74-year-old man | Liver | abdominal CT 17 days after endoscopic therapy showed a decrease (5 cm in diameter) of the main tumor in the liver, a marked decrease in the degree of early enhance- ment, and an increase in the nonenhancing area of the tumor (Fig. 2). The small lesion on Cantlie line was no longer visualized, and PIVKA-II levels return to normal values. On September 22, 2003, laparotomy was conducted; the small intrahepatic metastasis on Cantlie line could not be visualized even by intraoperative ultrasonography Microscopic examination demonstrated that the entire tumor had undergone coagulation necrosis. some vessels feeding the tumor were thickened and occluded due to arterial sclerosis | necrosis secondary to severe cholangitis after choledocholithiasis. | abdominal CT 17 days after endoscopic therapy showed a decrease (5 cm in diameter) of the main tumor in the liver, a marked decrease in the degree of early enhance- ment, and an increase in the nonenhancing area of the tumor (Fig. 2). The small lesion on Cantlie line was no longer visualized, and PIVKA-II levels return to normal values. On September 22, 2003, laparotomy was conducted; the small intrahepatic metastasis on Cantlie line could not be visualized even by intraoperative ultrasonography Microscopic examination demonstrated that the entire tumor had undergone coagulation necrosis. some vessels feeding the tumor were thickened and occluded due to arterial sclerosis | |
4-year-old male had a diagnosis of hepatitis B virus- related liver cirrhosis with complete portal vein thrombosis in 1989. | liver | No lesion was detected on CT performed on May 2000 when AFP was slightly elevated. | disturbance in hepatic circulation associated with portal vein thrombosis | No lesion was detected on CT performed on May 2000 when AFP was slightly elevated. | |
61-year-old male had a diagnosis of alcoholic liver cir- rhosis with portal hypertension thrombosis in April 2002 | liver | In July 2005, CT scan showed complete remission and normal AFP | disturbance in hepatic circulation associated with portal vein thrombosis | In July 2005, CT scan showed complete remission and normal AFP | |
60-year-old male, diagnosed with familiar hemochromatosis in 2000 | liver | In June 2004, MRI scan showed a clear, nonmeasurable volume regression of the tumoral thrombus that was confirmed in October 2004 when a new MRI scan failed to show any distinct focal liver lesion and AFP was normal. | disturbance in hepatic circulation associated with portal vein thrombosis | In June 2004, MRI scan showed a clear, nonmeasurable volume regression of the tumoral thrombus that was confirmed in October 2004 when a new MRI scan failed to show any distinct focal liver lesion and AFP was normal. | |
57-year-old man, hepatitis B virus-related chronic hepatitis over a period of 5 years | liver | Histologically, Frequent apoptosis, necrosis, or acidophilic degeneration of HCC cells was observed | local immune reactions | Histologically, Frequent apoptosis, necrosis, or acidophilic degeneration of HCC cells was observed | |
53-year-old man, history of hepatitis C and alcoholic cirrhosis | liver + lung mets + IVC thrombus | In December 2009 There was persistent left portal vein thrombosis as well as hepatic vein thrombosis, and the previously seen pulmonary nodules had either decreased in size or resolved. abdominal ultrasound prior to the scheduled liver biopsy did not show a definitive lesion, and the plan for biopsy was aborighted. in March 2010 CT chest at that time revealed resolution of the pulmonary nodules and hilar lymphadenopathy. Follow-up imaging showed no evidence of disease in the liver or lung parenchyma; however, the tumor thrombus persisted. | tumor ischemia in the setting of portal vein thrombosis + immune response | In December 2009 There was persistent left portal vein thrombosis as well as hepatic vein thrombosis, and the previously seen pulmonary nodules had either decreased in size or resolved. abdominal ultrasound prior to the scheduled liver biopsy did not show a definitive lesion, and the plan for biopsy was aborighted. in March 2010 CT chest at that time revealed resolution of the pulmonary nodules and hilar lymphadenopathy. Follow-up imaging showed no evidence of disease in the liver or lung parenchyma; however, the tumor thrombus persisted. | |
baby of a 32-year-old female | liver | Between 6 and 18 months the tumour gradually regressed in size, and US at 2 years of age found no evidence of tumour | Between 6 and 18 months the tumour gradually regressed in size, and US at 2 years of age found no evidence of tumour | ||
32-year-old woman, She had given birth 4 years before and had thereafter been taking an oral contraceptive containing 0.25 mg d-norgestrel and 0.05 mg ethinyl oestradiol | liver | MRI with manganese performed 18 months after initial presentation demonstrated a marked reduction in the size of the adenoma, which measured 24 mm. further follow-up MRI at 4 years demonstrated a normal liver with complete resolution of the tumour | MRI with manganese performed 18 months after initial presentation demonstrated a marked reduction in the size of the adenoma, which measured 24 mm. further follow-up MRI at 4 years demonstrated a normal liver with complete resolution of the tumour | ||
57-year-old man | Liver | 7 weeks later, a CT demonstrated a larger central area of necrosis within the HCC. Two months later, at a clinic visit, an alpha-fetoprotein value was markedly reduced at 87 ng/dl. A CT examination showed no evidence of HCC | auto- infarction | 7 weeks later, a CT demonstrated a larger central area of necrosis within the HCC. Two months later, at a clinic visit, an alpha-fetoprotein value was markedly reduced at 87 ng/dl. A CT examination showed no evidence of HCC | |
74-year-old man | liver | Histological examination of a biopsy specimen of the mass. demonstrated infarcted liver tissue and inflamed granulation tissue containing macrophages and m-year-old femaleibroblasts. There was no evidence of malig- nancy and no pathogens were identified. CT 5 months thereafter demonstrated a normal liver with no evidence of mass. | Histological examination of a biopsy specimen of the mass. demonstrated infarcted liver tissue and inflamed granulation tissue containing macrophages and m-year-old femaleibroblasts. There was no evidence of malig- nancy and no pathogens were identified. CT 5 months thereafter demonstrated a normal liver with no evidence of mass. | ||
54-year-old woman | Biliary system | microscopy of a CT-guided biopsy specimen found no evidence of malignancy. Repeat CT-guided biopsy and laparoscopic biopsy followed; histological examination demonstrated infiltration of the liver parenchyma and bile duct wall by mixed inflammatory cells. CT performed 6 months after laparoscopy showed marked regression in the volume of the central hepatic lesion | microscopy of a CT-guided biopsy specimen found no evidence of malignancy. Repeat CT-guided biopsy and laparoscopic biopsy followed; histological examination demonstrated infiltration of the liver parenchyma and bile duct wall by mixed inflammatory cells. CT performed 6 months after laparoscopy showed marked regression in the volume of the central hepatic lesion | ||
56-year-old Caucasian man, chronic HCV infection for 2 years. History of emphysema, hypertension, and gastroesophageal reflux. tattoo 7 years before. 40 pack-year history of smoking and had consumed five to six beers daily for 40 years. carpenter | Liver | 35 days later, the previously palpated mass had resolved. A complete blood count was normal, and AFP had returned to normal | exaggerated immune response or a compromised tumoral blood supply could explain the regression | 35 days later, the previously palpated mass had resolved. A complete blood count was normal, and AFP had returned to normal | |
67-year-old male. Cirrhosis | Liver | 2 years later AFP returned no normal values. US and CT didn't show any masses. | Ischemia | 2 years later AFP returned no normal values. US and CT didn't show any masses. | |
76-years-old man, history of heavy alcohol intake | Liver | CT scan revealed that the liver mass had decreased in size, with an interval change in maximum axial diameter from 6 cm to 3.3 cm and that the two other lesions had disappeared. | autoembolization | CT scan revealed that the liver mass had decreased in size, with an interval change in maximum axial diameter from 6 cm to 3.3 cm and that the two other lesions had disappeared. | |
56-year-old man, chronic alcohol abuse, hepatitis C, type 2 diabetes, heavy smoking, depression, and antisocial patterns of behaviour | Liver | MRI of the abdomen was repeated and results were compared with previous findings. A shrunken cirrhotic liver was found, with evi- dence of portal venous hypertension, including splenomegaly and ascites. The previously identi- fied enhancing areas of the left lobe of the liver, suspicious for HCC, were no longer present. | MRI of the abdomen was repeated and results were compared with previous findings. A shrunken cirrhotic liver was found, with evi- dence of portal venous hypertension, including splenomegaly and ascites. The previously identi- fied enhancing areas of the left lobe of the liver, suspicious for HCC, were no longer present. | ||
56-year-old male, psoriasis, gout, diabetes mellitus type II b, essential hypertension, reflux esophagitis II0 with a hiatal hernia, and a state after traumatic fracture of the right ribs 6 to 9 in 1989 | Liver | Another puncture of the focus was performed. At this time the tumor was 4 cm in diameter. Histologic assessment of the specimens from both tumors showed a mainly necrotic, multivocal, highly differentiated, trabecular-like HCC with a connective tissue-like pseudocapsule | tumor regression due to immune stim- ulation | Another puncture of the focus was performed. At this time the tumor was 4 cm in diameter. Histologic assessment of the specimens from both tumors showed a mainly necrotic, multivocal, highly differentiated, trabecular-like HCC with a connective tissue-like pseudocapsule | |
74-year-old male | Liver | US, during second addition, showed tumor size was 2.5 cm. Angiography and staging investigations did not show pathologic findings. Histologic assessment showed totally necrotic tumor tissue with small islets of a clear cell primary liver cell carcinoma, demarcated by granulated tissue rich in foam cells | tumor regression due to immune stim- ulation | US, during second addition, showed tumor size was 2.5 cm. Angiography and staging investigations did not show pathologic findings. Histologic assessment showed totally necrotic tumor tissue with small islets of a clear cell primary liver cell carcinoma, demarcated by granulated tissue rich in foam cells | |
52-year-old man, alcohol abuse | Liver + lung mets | Follow up CT scans 6 months later, revealed a decreased in size of the liver lesion to 3.5 cm, and almost complete resolution of the bilateral lung nodules with normal AFP. A CT scan of the chest and abdomen performed 9 months after the initial diagnosis, showed further regression in the size of the hepatic lesion, measuring 2.7 cm in diameter, and no new lung nodules. Pathology evaluation after surgery showed a 1.8 cm nodule with necrosis surrounded by fibrosis. | immune system | Follow up CT scans 6 months later, revealed a decreased in size of the liver lesion to 3.5 cm, and almost complete resolution of the bilateral lung nodules with normal AFP. A CT scan of the chest and abdomen performed 9 months after the initial diagnosis, showed further regression in the size of the hepatic lesion, measuring 2.7 cm in diameter, and no new lung nodules. Pathology evaluation after surgery showed a 1.8 cm nodule with necrosis surrounded by fibrosis. | |
68-year-old Japanese man, 7-year history of chronic Hep C, lung lobectomy for tuberculosis for tuberculosis and a blood transfusion. regular drinker, consuming approximately 540 mL of sake daily for 40 years | Liver | 1 month after reaching terminal stage, follow-up CT scan showed regression of more than 90% | 1 month after reaching terminal stage, follow-up CT scan showed regression of more than 90% | ||
74-year-old man with chronic hepatitis C-related cirrhosis and end-stage renal disease undergoing maintenance haemodialysis for years | Liver | 2.5 years later a CT showed a 2x2x2.5 ring calcification | 2.5 years later a CT showed a 2x2x2.5 ring calcification | ||
60 years old male patient, cirrhosis secondary to idiopathic hepatitis | Liver | The aneurysm began to contract after the 34th postoperative day. Then, was not detectable on the 37th postoperative day. It was assumed to have embolized spontaneously. | slow blood flow through the aneurysm | The aneurysm began to contract after the 34th postoperative day. Then, was not detectable on the 37th postoperative day. It was assumed to have embolized spontaneously. | |
A 50-year-old woman was diagnosed with chronic hepatitis C at the age of 33 years, but IFN therapy was contra-indicated, because she exhibited pancytopenia Transcatheter arterial chemoembolization (TACE) to treat hepatocellular carcinoma (HCC) was performed on several occasions from the time she was 47 years of age. However, further treatment became difficult because of a lack of spare hepatic capacity | Liver | no HCV-RNA was evident by day 87 post-LT | immunological response | no HCV-RNA was evident by day 87 post-LT | |
52-year-old man, was diagnosed with chronic HCV infection (serological type 2) at 47 -year-old Was naıve in the context of HCV therapy, because his condition was complicated by ascites and HCC. The cancer could not be treated radically because of his poor liver function | Liver | By day 115 after LT, the HCV RNA status resolved spontaneously, and the patient achieved continuous viral disappearance | immunological response | By day 115 after LT, the HCV RNA status resolved spontaneously, and the patient achieved continuous viral disappearance | |
70-year-old man. alcohol-related cirrhosis | Liver | 2 years later, a new CT disclosed tumoral regression of HCCs | immunologic reactions | 2 years later, a new CT disclosed tumoral regression of HCCs | |
64-year-old man. History of atrial fibrillation (on a stable dose of a direct oral anticoagulant for years) | Liver | follow-up MRI approximately 9 weeks after the initial MRI showed a decrease in size to 1.6 cm and a decrease in arterial enhancement of the biopsy-proven HCC. The patient was taken to the operating room for a planned resection, at which time the surgeon noted no evidence of tumor at the site predicted by the pre-operative imaging. Instead, only slight dimpling was noted in segment 4a at the expected site. | immunologic reactions | follow-up MRI approximately 9 weeks after the initial MRI showed a decrease in size to 1.6 cm and a decrease in arterial enhancement of the biopsy-proven HCC. The patient was taken to the operating room for a planned resection, at which time the surgeon noted no evidence of tumor at the site predicted by the pre-operative imaging. Instead, only slight dimpling was noted in segment 4a at the expected site. | |
64-year-old male | Liver | Several months later, when the patient followed up for his HCC, there was near complete spontaneous regression of the liver masses and lung nodules. | The more peripheral location could predispose the tumor to ischemia, given the more tenuous blood supply, particularly in cirrhotic livers and subcapsular masses. Furthermore, the subcapsular location and potentially local disruption of the capsule may predispose a lesion for immunologic presentation. | Several months later, when the patient followed up for his HCC, there was near complete spontaneous regression of the liver masses and lung nodules. | |
65-year-old male. History of cirrhosis due to chronic HCV infection | Liver | Over the course of 15 months in hospice, the patient made significant functional gains. This unexpected recovery prompted an AFP recheck, which revealed a significant reduction. A CT scan showed a reduction in infiltrative disease with near complete resolution of the massive infiltrative right hepatic lobe mass | The more peripheral location could predispose the tumor to ischemia, given the more tenuous blood supply, particularly in cirrhotic livers and subcapsular masses. Furthermore, the subcapsular location and potentially local disruption of the capsule may predispose a lesion for immunologic presentation. | Over the course of 15 months in hospice, the patient made significant functional gains. This unexpected recovery prompted an AFP recheck, which revealed a significant reduction. A CT scan showed a reduction in infiltrative disease with near complete resolution of the massive infiltrative right hepatic lobe mass | |
57-year-old female. History of cirrhosis due to HCV infection and prior HCC in remission, treated with surgical wedge resection three years prior to presentation | Liver | Repeat imaging prior to a planned hepatic angiogram showed spontaneous regression of the 2 cm LI-RADS 5 lesion. AFP had also decreased from 27.2 ng/mL to 5.5 ng/mL. | The more peripheral location could predispose the tumor to ischemia, given the more tenuous blood supply, particularly in cirrhotic livers and subcapsular masses. Furthermore, the subcapsular location and potentially local disruption of the capsule may predispose a lesion for immunologic presentation. | Repeat imaging prior to a planned hepatic angiogram showed spontaneous regression of the 2 cm LI-RADS 5 lesion. AFP had also decreased from 27.2 ng/mL to 5.5 ng/mL. | |
68-year-old Caucasian man. History of chronic hepatitis C virus (HCV) infection, genotype 1b, in the context of blood transfusion in 1977. History of prostatic adenocarcinoma and underwent surgery and radiotherapy. | liver | Ten months later, AFP markedly decreased (28ng/mL), and abdominal MRI showed decreasing size, number, and vascularisation of lesions previously described | A. muricata compounds have cytotoxic activity against liver cancer cells | Ten months later, AFP markedly decreased (28ng/mL), and abdominal MRI showed decreasing size, number, and vascularisation of lesions previously described | |
74-year-old white male. History of obesity, type 2 diabetes, dyslipidemia, hypertension, hypothyroidism, and prostatism. He had coronary artery stenoses requiring bypass grafting and also had a cholecystectomy. His medications included aspirin, amlodipine, metoprolol, atorvastatin, insulin, metformin, ferrous sulfate, finasteride, and levothyroxine. | Liver | One year after the initial diagnosis, a contrast-enhanced abdominal CT showed large ascites, nodular liver, a 2.5-cm ill-defined, non-enhancing right hepatic lobe lesion and resolution of expansile right portal and main portal vein thrombus. Repeat testing showed persistently normal serum AFP levels. | likely involved vascular phenomena and immunologic pathways | One year after the initial diagnosis, a contrast-enhanced abdominal CT showed large ascites, nodular liver, a 2.5-cm ill-defined, non-enhancing right hepatic lobe lesion and resolution of expansile right portal and main portal vein thrombus. Repeat testing showed persistently normal serum AFP levels. | |
43-year-old man. History of alcohol-associated cirrhosis, type 2 diabetes, and hypertension | Liver | Surveillance MRI revealed a tumor reduction to 0.9 x 0.9 cm, suggestive of HCC autoinfarction | it is possible that the tumor regressed because of it outgrowing its blood supply | Surveillance MRI revealed a tumor reduction to 0.9 x 0.9 cm, suggestive of HCC autoinfarction | |
54-year-old man. History of cirrhosis due to hepatitis B. HCC found in segment 7 and treated successfully with transarterial chemoembolization 4 months before presentation | Liver | One month later, a triple-phase computed tomography scan showed tumor shrinkage to 4.5 x 3.2 cm, suggestive of autoinfarction | it is possible that the tumor regressed because of it outgrowing its blood supply | One month later, a triple-phase computed tomography scan showed tumor shrinkage to 4.5 x 3.2 cm, suggestive of autoinfarction | |
81-year-old female. History of chronic active hepatitis B. She had been taking the antiviral drug entecavir. Past medical history included hypertension, diabetes, and type B aortic dissection, which were all medically managed. Family history was significant for colon cancer in one of her sons. | Lung, Liver | On a routine follow-up 5 months from RFA, she reported feeling well with greatly improved symptoms. CT at that time showed significant decrease in size of the multiple lung nodules and the liver masses. Repeat CT scans 8 months and 14 months after RFA again showed further decrease in the size of the lung lesions. | self-anti-tumor immune response | On a routine follow-up 5 months from RFA, she reported feeling well with greatly improved symptoms. CT at that time showed significant decrease in size of the multiple lung nodules and the liver masses. Repeat CT scans 8 months and 14 months after RFA again showed further decrease in the size of the lung lesions. | |
84-year-old Japanese female with hepatitis C virus (HCV)-associated chronic hepatitis and diabetes mellitus treated with insulin | Liver | Small nodules were entirely composed of necrotic tissue, and a thick trabecular pattern could be recognized by reticulin staining, indicating moderately differentiated HCC with extensive coagulative necrosis, existing in a nodule-in-nodule pattern. | the immune reaction might have played an important role | Small nodules were entirely composed of necrotic tissue, and a thick trabecular pattern could be recognized by reticulin staining, indicating moderately differentiated HCC with extensive coagulative necrosis, existing in a nodule-in-nodule pattern. | |
A 56-year-old (at first presentation) Japanese man. History of hepatitis C virus (HCV)-related liver cirrhosis and type 2 DM (750 mg/day of metformin and 1 mg/day of glimepiride). | Liver | Ten weeks since the initiation of SGLT2i treatment, angiography of the hepatic artery revealed no tumor staining. Tumor staining was also not seen in angiography of the collateral arteries. Furthermore, in contrast-enhanced computed tomography scan, the arterial phase hyperenhancement of the contrast agent within the mass disappeared. Moreover, blood biochemical examination showed that the elevated serum AFP level decreased within normal limits, indicating spontaneous regression of HCC | Since insulin resistance is a potent risk factor for HCC proliferation 13, SGLT2i may suppress HCC through an improvement of insulin resistance. | Ten weeks since the initiation of SGLT2i treatment, angiography of the hepatic artery revealed no tumor staining. Tumor staining was also not seen in angiography of the collateral arteries. Furthermore, in contrast-enhanced computed tomography scan, the arterial phase hyperenhancement of the contrast agent within the mass disappeared. Moreover, blood biochemical examination showed that the elevated serum AFP level decreased within normal limits, indicating spontaneous regression of HCC | |
83-year-old man with hepatitis C virus infection. He had received a diagnosis of HCC and had been treated by radiofrequency ablation and transcatheter arterial chemoembolization (TACE) since the age of 74 years. past medical history of hypertension, diabetes mellitus, and benign prostatic hyperplasia at 60 years of age and cerebral infarction at 72 years of age He had been receiving oral treatment with diuretics and a preparation of branched chain amino acid | Liver | His general condition gradually improved. A CT scan 16 months after the last TACE revealed the disappearance of the thrombus of the left branch of the portal vein and atrophic change of the left lobe. The tumor thrombus in the main portal vein and the tumors in the left lobe also disappeared | The massive main portal vein tumor thrombus decreased portal blood flow, and the arterioportal shunt decreased blood supply from the hepatic artery to the tumors. These disturbances of the blood circulation could have induced hypoxia of rapidly increased tumors and precipitated a tumor regression | His general condition gradually improved. A CT scan 16 months after the last TACE revealed the disappearance of the thrombus of the left branch of the portal vein and atrophic change of the left lobe. The tumor thrombus in the main portal vein and the tumors in the left lobe also disappeared | |
73-year-old Japanese woman with untreated chronic hepatitis C. Smoking history of 37.5 pack-years | Liver | Seven months after the initial diagnosis revealed marked regression of the hypervascular HCC. The tumor thrombus in the left branch of the main portal vein had disappeared. Her tumor markers were notably reduced. | the tumor thrombus in the left branch of the main portal vein likely caused ischemia and subsequent necrosis of the tumor. Furthermore, the patient’s decision to quit smoking may have reduced oxidative stress and enhanced their natural immune responses against the tumor, contributing to SR. These findings suggest that both tumor hypoxia and immune activation may have played critical roles in the SR | Seven months after the initial diagnosis revealed marked regression of the hypervascular HCC. The tumor thrombus in the left branch of the main portal vein had disappeared. Her tumor markers were notably reduced. | |
79-year-old Chinese female. History of chronic hepatitis C and well-controlled essential hypertension, for which she took valsartan 80 mg once daily | Liver, Lung | At two months follow-up CT, the lung lesions had completely disappeared, and there was a significant decrease in the size of the primary liver lesion. Serum AFP levels had fallen to almost within the normal range | None reported | At two months follow-up CT, the lung lesions had completely disappeared, and there was a significant decrease in the size of the primary liver lesion. Serum AFP levels had fallen to almost within the normal range | |
70-year-old woman. 10-year history of primary biliary cholangitis (PBC) and reumathoid arthirtis (RA) | Liver | After two months of observation, the tumors spontaneously regressed and nearly vanished | None reported | After two months of observation, the tumors spontaneously regressed and nearly vanished | |
71-year-old man. He had undergone drug-eluting stent grafting to the coronary arteries for angina pectoris 4 years before and had been receiving MTX (12 mg p.o. once a week) to treat his rheumatoid arthritis for more than 6 years | liver | Enhanced CT 2 months after discharge showed complete disappearance of small EHE lesions and marked shrinkage of large EHE lesions. Follow-up CT taken 12 months after the biliary drainage showed complete regression of the liver EHE lesions | Anti-icteric therapy might have contributed to the spontaneous regression of the multiple liver EHEs through biliary decompression. | Enhanced CT 2 months after discharge showed complete disappearance of small EHE lesions and marked shrinkage of large EHE lesions. Follow-up CT taken 12 months after the biliary drainage showed complete regression of the liver EHE lesions | |
67-year-old man. Medical history of Sjögren’s syndrome and psoriasis with no active treatment and hypothyroidism with levothyroxine supplementation. Smoker of 1 pack of cigarettes per day for more than 40 years. | liver, lung, pancreas | PET/CT 3 weeks after admission showed that the multiple masses spontaneously regressed. A week later, a biopsy of the liver mass, which had decreased in size from 45 to 30 mm, revealed extensive necrosis in most areas of the mass and low Ki-67 expression. At the fourmonth follow-up, the masses continued to regress, with some completely disappearing following smoking cessation and watchful waiting | Smoking cessation can contribute to the improvement of the tumor microenvironment, possibly leading to reactivation of immune cells and tumor regression | PET/CT 3 weeks after admission showed that the multiple masses spontaneously regressed. A week later, a biopsy of the liver mass, which had decreased in size from 45 to 30 mm, revealed extensive necrosis in most areas of the mass and low Ki-67 expression. At the fourmonth follow-up, the masses continued to regress, with some completely disappearing following smoking cessation and watchful waiting | |
The patient is a 64-year-old man, himself a professional in psychological healing. | In two weeks he reported the first signs of improvement. In six weeks he was able to discontinue the use of the enema, and had regained the use of his bowels to the extent of passing stools which he described as like a pencil. In two months he was sleeping the night through without getting up. At this stage he was extremely confident that he had beaten the growth, and he went for a month’s holiday to another State. | The extreme reduction of anxiety in these patients triggers off the mechanism as that which becomes active in the rare spontaneous remissions. This would be consistent with the observation that spontaneous remissions are often associated with some kind of religious experience or profound psychological reaction. | In two weeks he reported the first signs of improvement. In six weeks he was able to discontinue the use of the enema, and had regained the use of his bowels to the extent of passing stools which he described as like a pencil. In two months he was sleeping the night through without getting up. At this stage he was extremely confident that he had beaten the growth, and he went for a month’s holiday to another State. | ||
5-year-old girl, had blood in the stools for 3 weeks | The remaining polyp had clearly decreased in size and then measured 6 x 6 millimeters and, six months later, at a further control examination, it had decreased still more, the measurement then being 4 x 3 millimeters | The remaining polyp had clearly decreased in size and then measured 6 x 6 millimeters and, six months later, at a further control examination, it had decreased still more, the measurement then being 4 x 3 millimeters | |||
Girl aged 5 1/2 years, had bleeding from the rectum for a year | Eighteen months later, on control examination, the polyp had clearly decreased in size; it then measured 7 x 7 millimeters | Eighteen months later, on control examination, the polyp had clearly decreased in size; it then measured 7 x 7 millimeters | |||
A 65-year-old alcoholic black man, retired manual laborer in a spark plug factory | Jaundice resolved, no evidence of tumor demonstrable by radionuclide scanning or laparoscopic liver biopsy, liver scan normal, alphafetoprotein negative | Abstention from alcohol | Jaundice resolved, no evidence of tumor demonstrable by radionuclide scanning or laparoscopic liver biopsy, liver scan normal, alphafetoprotein negative | ||
A 50-year-old male carpenter from Southern China | epigastric distension decreased, liver decreased progressively in size, fluid retention disappeared, no clinical evidence of HCC, minimal biochemical abnormalities, no dysplasia, no clinical or biochemical evidence of liver cirrhosis, no feature of residual HCC, asymptomatic, and apparently free from recurrence | regression of HCC might occur by involution rather than maturation, regressed HCC might be replaced by surrounding tissue instead of leaving behind dysplasia | epigastric distension decreased, liver decreased progressively in size, fluid retention disappeared, no clinical evidence of HCC, minimal biochemical abnormalities, no dysplasia, no clinical or biochemical evidence of liver cirrhosis, no feature of residual HCC, asymptomatic, and apparently free from recurrence | ||
78-year-old Japanese man with chronic liver disease, no history of alcoholic ingestion | Tumors disappeared with normalization of the alphafetoprotein level, the radiolucent area around the fracture site of the femur became consolidated | Tumors disappeared with normalization of the alphafetoprotein level, the radiolucent area around the fracture site of the femur became consolidated | |||
63-year-old white woman, no relevant past history or family history, no previous history of jaundice or hepatitis, no excessive alcohol intake, no previous operations or blood transfusions, no drugs, recent weight loss | Asymptomatic after five months, weight gain, cleared metastases, considerable shrinkage of the tumour, cryptogenic macronodular cirrhosis with no evidence of carcinoma in repeat biopsy, normal liver function tests after twelve months | Asymptomatic after five months, weight gain, cleared metastases, considerable shrinkage of the tumour, cryptogenic macronodular cirrhosis with no evidence of carcinoma in repeat biopsy, normal liver function tests after twelve months | |||
a woman, aged 48 | I could no longer feel the growth at the ampulla | I could no longer feel the growth at the ampulla | |||
A 5 1/2-month-old white boy | Liver had decreased remarkably in size two years after surgery, development of dense mottled calcification in the right lobe of the liver at 21 months of age, increase in the density of the calcifications at age 8 years, contraction and increased density in the right upper quadrant calcifications in adulthood | Liver had decreased remarkably in size two years after surgery, development of dense mottled calcification in the right lobe of the liver at 21 months of age, increase in the density of the calcifications at age 8 years, contraction and increased density in the right upper quadrant calcifications in adulthood | |||
A 7 1/2-month-old healthy white male infant | On a follow-up examination eight months later, the hepatomegaly had improved markedly. The abdominal girth was noted to be 49 centimeters. Many of the previously noted lesions had disappeared, and those that remained were much less obvious. | Spontaneous regression | On a follow-up examination eight months later, the hepatomegaly had improved markedly. The abdominal girth was noted to be 49 centimeters. Many of the previously noted lesions had disappeared, and those that remained were much less obvious. | ||
55-year-old woman, had been on norethynodrel with mestranol (Envois®, G. D. Searle & Co., Chicago, Illinois), 5 mg/day, for about 10 years without interruption | spontaneous regression of the lesion | spontaneous regression of the lesion | |||
32-year-old woman, history of oral contraceptive use (norgestrel 0.25 milligrams, ethinyl estradiol 0.05 milligrams) for 6 years | Discontinuation of contraceptives led to symptom relief within a few weeks, normal physical examination of the liver in June 1978 and September 1979, normal liver enzymes, no evidence of residual tumor in technetium scan and ultrasonography of the liver in September 1979 | Discontinuation of contraceptives led to symptom relief within a few weeks, normal physical examination of the liver in June 1978 and September 1979, normal liver enzymes, no evidence of residual tumor in technetium scan and ultrasonography of the liver in September 1979 | |||
Author–year | Age/sex | Primary site | Remission site | Proposed mechanisms | Follow-up |
|---|
Author–year | Age/sex | Primary site | Remission site | Proposed mechanisms | Follow-up |
|---|
Author–year | Age/sex | Primary site | Remission site | Proposed mechanisms | Follow-up |
|---|
References:
- Forner, A., et al. "Hepatocellular carcinoma." The Lancet 391.10127 (2018): 1301-1314.
- El-Serag, H. B., and K. L. Kanwal. "Epidemiology of hepatocellular carcinoma." Clinics in Liver Disease 22.2 (2018): 253-264.
- Cole, W. H. "Spontaneous regression of cancer." Annals of the New York Academy of Sciences 114.2 (1964): 742-750.
- Everson, T. C., and W. H. Cole. Spontaneous regression of cancer. WB Saunders, 1966.
- Alqutub, A., Peck, D., & Marotta, P. (2011). spontaneous regression of a large hepatocellular carcinoma: case report. German medical science : GMS e-journal, 9, Doc07. https://doi.org/10.3205/000130
- Arora, N., & Madhusudhana, S. (2011). spontaneous regression of hepatocellular cancer: case report and review of literature. Gastrointestinal cancer research : GCR, 4(4), 141–143.
- Bastawrous, S., Kogut, M. J., & Bhargava, P. (2012). spontaneous regression of hepatocellular carcinoma in a cirrhotic patient: possible vascular hypothesis. Singapore medical journal, 53(10), e218–e221.
- Bhardwaj, N., Li, M., Price, T., & Maddern, G. J. (2014). spontaneous regression of a biopsy confirmed hepatocellular carcinoma. BMJ case reports, 2014, bcr2014204897. https://doi.org/10.1136/bcr-2014-204897
- Jang, T. J., Lee, J. I., Kim, D. H., Kim, J. R., & Lee, H. K. (2000). spontaneous regression of hepatocellular carcinoma--a case report. The Korean journal of internal medicine, 15(2), 147–150. https://doi.org/10.3904/kjim.2000.15.2.147
- Kim, S. B., Kang, W., Shin, S. H., Lee, H. S., Lee, S. H., Choi, G. H., & Park, J. Y. (2015). spontaneous neoplastic remission of hepatocellular carcinoma. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 65(5), 312–315. https://doi.org/10.4166/kjg.2015.65.5.312
- Lim, D. H., Park, K. W., & Lee, S. I. (2014). spontaneous complete regression of multiple metastases of hepatocellular carcinoma: A case report. Oncology letters, 7(4), 1225–1228. https://doi.org/10.3892/ol.2014.1869
- Matsuoka, S., Tamura, A., Moriyama, M., Fujikawa, H., Mimatsu, K., Oida, T., & Sugitani, M. (2015). Pathological evidence of the cause of spontaneous regression in a case of resected hepatocellular carcinoma. Internal medicine (Tokyo, Japan), 54(1), 25–30. https://doi.org/10.2169/internalmedicine.54.2981
- Meza-Junco, J., monthstaño-Loza, A. J., MARTinez-Benítez, B., & Cabrera-Aleksandrova, T. (2007). spontaneous partial regression of hepatocellular carcinoma in a cirrhotic patient. Annals of hepatology, 6(1), 66–69. https://doi.org/10.1016/S1665-2681(19)31957-X
- Nakajima, T., Moriguchi, M., Watanabe, T., Noda, M., Fuji, N., Minami, M., Itoh, Y., & Okanoue, T. (2004). Recurrence of hepatocellular carcinoma with rapid growth after spontaneous regression. World journal of gastroenterology, 10(22), 3385–3387. https://doi.org/10.3748/wjg.v10.i22.3385
- Noij, D. P., & van Der Linden, P. W. (2017). spontaneous regression of hepatocellular carcinoma in a Caucasian male patient: A case report and review of the literature. Molecular and clinical oncology, 6(2), 225–228. https://doi.org/10.3892/mco.2016.1115
- Nouso, K., Uematsu, S., Shiraga, K., Okamoto, R., Harada, R., Takayama, S., Kawai, W., Kimura, S., Ueki, T., Okano, N., Nakagawa, M., Mizuno, M., Araki, Y., & Shiratori, Y. (2005). Regression of hepatocellular carcinoma during vitamin K administration. World journal of gastroenterology, 11(42), 6722–6724. https://doi.org/10.3748/wjg.v11.i42.6722
- Ohtani, H., Yamazaki, O., Matsuyama, M., Horii, K., Shimizu, S., Oka, H., Nebiki, H., Kioka, K., Kurai, O., Kawasaki, Y., Manabe, T., Murata, K., Matsuo, R., & Inoue, T. (2005). spontaneous regression of hepatocellular carcinoma: report of a case. Surgery today, 35(12), 1081–1086. https://doi.org/10.1007/s00595-005-3066-8
- Okano, A., & Ohana, M. (2015). spontaneous regression of hepatocellular carcinoma: its imaging course leading to complete disappearance. Case reports in oncology, 8(1), 94–100. https://doi.org/10.1159/000375486
- Okano, A., Ohana, M., Kusumi, F., & Nabeshima, M. (2013). spontaneous Regression of Hepatocellular Carcinoma due to Disrupatiention of the Feeding artery. Case reports in oncology, 6(1), 180–185. https://doi.org/10.1159/000350682
- Saito, T., Naito, M., Matsumura, Y., Kita, H., Kanno, T., Nakada, Y., Hamano, M., Chiba, M., Maeda, K., Michida, T., & Ito, T. (2014). spontaneous regression of a large hepatocellular carcinoma with multiple lung metastases. Gut and liver, 8(5), 569–574. https://doi.org/10.5009/gnl13358
- Tocci, G., Conte, A., Guarascio, P., & Visco, G. (1990). spontaneous remission of hepatocellular carcinoma after massive gastrointestinal haemorrhage. BMJ (Clinical research ed.), 300(6725), 641–642. https://doi.org/10.1136/bmj.300.6725.641
- Uenishi, T., Hirohashi, K., Tanaka, H., Ikebe, T., & Kinoshita, H. (2000). spontaneous regression of a large hepatocellular carcinoma with portal vein tumor thrombi: report of a case. Surgery today, 30(1), 82–85. https://doi.org/10.1007/PL00010054
- Wang, Z., Ke, Z. F., Lu, X. F., Luo, C. J., Liu, Y. D., Lin, Z. W., & Wang, L. T. (2015). The clue of a possible etiology about spontaneous regression of hepatocellular carcinoma: a perspective on pathology. OncoTargets and therapy, 8, 395–400. https://doi.org/10.2147/OTT.S79102
- Yang, S. Z., Zhang, W., Yuan, W. S., & Dong, J. H. (2015). Recurrence of Hepatocellular Carcinoma With Epithelial-Mesenchymal Transition After spontaneous Regression: A Case report. Medicine, 94(28), e1062. https://doi.org/10.1097/MD.0000000000001062
- Yano, Y., Yamashita, F., Kuwaki, K., Fukumori, K., Kato, O., Ki-year-old maleatsu, K., Sakai, T., Yamamoto, H., Yamasaki, F., Ando, E., & Sata, M. (2005). partial spontaneous regression of hepatocellular carcinoma: a case with high concentrations of serum lens culinaris agglutinin-reactive alpha fetoprotein. The Kurume medical journal, 52(3), 97–103. https://doi.org/10.2739/kurumemedj.52.97
- Feo, C. F., Marrosu, A., Scanu, A. M., Ginesu, G. C., Fancellu, A., Migaleddu, V., & Porcu, A. (2004). spontaneous regression of hepatocellular carcinoma: report of a case. European journal of gastroenterology & hepatology, 16(9), 933–936. https://doi.org/10.1097/00042737-200409000-00020
- Sasaki, T., Fukumori, D., Yamamoto, K., Yamamoto, F., Igimi, H., & Yamashita, Y. (2013). Management considerations for purporighted spontaneous regression of hepatocellular carcinoma: a case report. Case reports in gastroenterology, 7(1), 147–152. https://doi.org/10.1159/000350501
- Blondon, H., Fritsch, L., & Cherqui, D. (2004). Two cases of spontaneous regression of multicentric hepatocellular carcinoma after intraperitoneal rupture: possible role of immune mechanisms. European journal of gastroenterology & hepatology, 16(12), 1355–1359. https://doi.org/10.1097/00042737-200412000-00020
- Blondon, H., Fritsch, L., & Cherqui, D. (2004). Two cases of spontaneous regression of multicentric hepatocellular carcinoma after intraperitoneal rupture: possible role of immune mechanisms. European journal of gastroenterology & hepatology, 16(12), 1355–1359. https://doi.org/10.1097/00042737-200412000-00020
- Cheng, H. M., & Tsai, M. C. (2004). Regression of hepatocellular carcinoma spontaneous or herbal medicine related?. The American journal of Chinese medicine, 32(4), 579–585. https://doi.org/10.1142/S0192415X04002211
- Chiesara, F., Spagnolo, A., Koch, M., & Moretti, A. (2014). A case of hepatocellular carcinoma: spontaneous regression?. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 46(7), 659–660. https://doi.org/10.1016/j.dld.2014.02.007
- Clos, A., Hernández, A., Sánchez, M. D., Tenesa, M., Julián, J. F., Armengol, C., & Sala, M. (2017). spontaneous regression of hepatocellular carcinoma. A case report. Regresión espotaneousánea de carcinoma hepatocelular. A propósito de un caso. Gastroenterologia y hepatologia, 40(4), 286–288. https://doi.org/10.1016/j.gastrohep.2016.02.003
- Del Poggio, P., Mattiello, M., Gilardoni, L., Jamoletti, C., Colombo, S., & Zabbialini, G. (2009). The mysterious case of spontaneous disappearance of hepatocellular carcinoma. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 41(7), e21–e25. https://doi.org/10.1016/j.dld.2008.02.001
- Gómez Sanz, R., Moreno Gonzalez, E., Colina Ruiz-Delgado, F., Garcia-Muñoz, H., Ochando Cerdan, F., & Gonzalez-Pinto, I. (1998). spontaneous regression of a recurrent hepatocellular carcinoma. Digestive diseases and sciences, 43(2), 323–328. https://doi.org/10.1023/a:1018802321581
- Grossmann, M., Hoermann, R., Weiss, M., Jauch, K. W., Oerightel, H., Staebler, A., Mann, K., & Engelhardt, D. (1995). spontaneous regression of hepatocellular carcinoma. The American journal of gastroenterology, 90(9), 1500–1503.
- Harimoto, N., Shirabe, K., Kajiyama, K., Gion, T., Takenaka, M., Nagaie, T., & Maehara, Y. (2012). spontaneous regression of multiple pulmonary recurrences of hepatocellular carcinoma after hepatectomy: report of a case. Surgery today, 42(5), 475–478. https://doi.org/10.1007/s00595-011-0030-7
- Ikuta, S., Miki, C., Ookura, E., Tonouchi, H., & Kusunoki, M. (2002). spontaneous regression of a metastatic liver tumor: report of a case. Surgery today, 32(9), 844–848. https://doi.org/10.1007/s005950200165
- Kaczynski, J., Hansson, G., Remotti, H., & Wallerstedt, S. (1998). spontaneous regression of hepatocellular carcinoma. Histopathology, 32(2), 147–150. https://doi.org/10.1046/j.1365-2559.1998.00340.x
- Kato, H., Nakamura, M., Muramatsu, M., Orito, E., Ueda, R., & Mizokami, M. (2004). spontaneous regression of hepatocellular carcinoma: two case reports and a literature review. Hepatology research : the official journal of the Japan Society of Hepatology, 29(3), 180–190. https://doi.org/10.1016/j.hepres.2004.03.005
- Kojima, H., Tanigawa, N., Kariya, S., Komemushi, A., Shomura, Y., Sawada, S., Arai, E., & Yokota, Y. (2006). A case of spontaneous regression of hepatocellular carcinoma with multiple lung metastases. Radiation medicine, 24(2), 139–142. https://doi.org/10.1007/BF02493281
- Komatsu, H., Imamura, S., Shimizu, T., Tsunoda, Y., Ito, T., Imai, J., Nagakubo, S., Morohoshi, Y., & Fujita, Y. (2012). spontaneous regression of hepatocellular carcinoma repeated 3 times with invasion of portal vein and inferior vena cava: report on a rare case. Clinical journal of gastroenterology, 5(1), 35–41. https://doi.org/10.1007/s12328-011-0266-1
- Kondo, S., Okusaka, T., Ueno, H., Ikeda, M., & Morizane, C. (2006). spontaneous regression of hepatocellular carcinoma. International journal of clinical oncology, 11(5), 407–411. https://doi.org/10.1007/s10147-006-0591-4
- Lee, H. S., Lee, J. S., Woo, G. W., Yoon, J. H., & Kim, C. Y. (2000). Recurrent hepatocellular carcinoma after spontaneous regression. Journal of gastroenterology, 35(7), 552–556. https://doi.org/10.1007/s005350070080
- Li, A. J., Wu, M. C., Cong, W. M., Shen, F., & Yi, B. (2003). spontaneous complete necrosis of hepatocellular carcinoma: a case report. Hepatobiliary & pancreatic diseases international : HBPD INT, 2(1), 152–154.
- Luciani, A., Rahmouni, A., Achab, H., Mathieu, D., Jazaerli, N., & Bouanane, M. (2001). CT de monthstration of the spontaneous regression of a hypervascular lesion in cirrhotic liver. Cancer imaging : the official publication of the International Cancer Imaging Society, 1(2), 1–3. https://doi.org/10.1102/1470-7330.2001.001
- Misawa, K., Hata, Y., Manabe, K., Matsuoka, S., Saito, M., Takada, J., & Sano, F. (1999). spontaneous regression of hepatocellular carcinoma. Journal of gastroenterology, 34(3), 410–414. https://doi.org/10.1007/s005350050285
- Nakai, T., Shimomura, T., & Hirokawa, F. (2001). spontaneous regression of recurrent hepatocellular carcinoma after TAE: possible mechanisms of immune mediation. International journal of clinical oncology, 6(3), 149–152. https://doi.org/10.1007/pl00012098
- Nakayama S. (2012). spontaneous regression of hepatocellular carcinoma. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 31(5), 267–270. https://doi.org/10.1007/s12664-012-0220-2
- Nam, S. W., Han, J. Y., Kim, J. I., Park, S. H., Cho, S. H., Han, N. I., Yang, J. M., Kim, J. K., Choi, S. W., Lee, Y. S., Chung, K. W., & Sun, H. S. (2005). spontaneous regression of a large hepatocellular carcinoma with skull metastasis. Journal of gastroenterology and hepatology, 20(3), 488–492. https://doi.org/10.1111/j.1440-1746.2005.03243.x
- Nishijima, N., Marusawa, H., Kita, R., Osaki, Y., & Chiba, T. (2009). Education and Imaging. Hepatobiliary and pancreatic: spontaneous regression of hepatocellular cancer demonstrated by contrast-enhanced ultrasonography. Journal of gastroenterology and hepatology, 24(6), 1153. https://doi.org/10.1111/j.1440-1746.2009.05884.x
- Ohta, H., Sakamoto, Y., Ojima, H., Yamada, Y., Hibi, T., Takahashi, Y., Sano, T., Shimada, K., & Kosuge, T. (2005). spontaneous regression of hepatocellular carcinoma with complete necrosis: case report. abdominal imaging, 30(6), 734–737. https://doi.org/10.1007/s00261-005-0313-9
- Oquiñena, S., Iñarrairaegui, M., Vila, J. J., Alegre, F., Zozaya, J. M., & Sangro, B. (2009). spontaneous regression of hepatocellular carcinoma: three case reports and a categorized review of the literature. Digestive diseases and sciences, 54(5), 1147–1153. https://doi.org/10.1007/s10620-008-0447-z
- Park, H. S., Jang, K. Y., Kim, Y. K., Cho, B. H., & Moon, W. S. (2009). Hepatocellular carcinoma with massive lymphoid infiltration: a regressing phenomenon?. Pathology, research and practice, 205(9), 648–652. https://doi.org/10.1016/j.prp.2009.01.001
- Pectasides, E., Miksad, R., Pyatibrat, S., Srivastava, A., & Bullock, A. (2016). spontaneous Regression of Hepatocellular Carcinoma with Multiple Lung Metastases: A Case report and Review of the Literature. Digestive diseases and sciences, 61(9), 2749–2754. https://doi.org/10.1007/s10620-016-4141-2
- Peddu, P., Huang, D., Kane, P. A., Karani, J. B., & Knisely, A. S. (2008). Vanishing liver tumours. Clinical radiology, 63(3), 329–339. https://doi.org/10.1016/j.crad.2007.08.009
- Randolph, A. C., Tharalson, E. M., & Gilani, N. (2008). spontaneous regression of hepatocellular carcinoma is possible and might have implications for future therapies. European journal of gastroenterology & hepatology, 20(8), 804–809. https://doi.org/10.1097/MEG.0b013e3282f2bbcc
- Reñé Espinet JM, Ruiz González A, Buenestado García J, Rubio Caballero M. Regresión espotaneousánea de un carcinoma hepatocelular [The spontaneous regression of a hepatocellular carcinoma]. Rev Esp Enferm Dig. 1992 Jan;81(1):60-1. Spanish. PMID: 1372172.
- SibARTie, V., MoriARTy, J., & Crowe, J. (2008). spontaneous regression of hepatocellular carcinoma. The American journal of gastroenterology, 103(4), 1050–1051. https://doi.org/10.1111/j.1572-0241.2007.01772_14.x
- Stefanczyk-Sapieha, L., & Fainsinger, R. L. (2008). Hepatocellular carcinoma: misdiagnosis or spontaneous remission?. Journal of palliative care, 24(1), 55–59.
- Stoelben, E., Koch, M., Hanke, S., Lossnitzer, A., Gaerightner, H. J., Schentke, K. U., Bunk, A., & Saeger, H. D. (1998). spontaneous regression of hepatocellular carcinoma confirmed by surgical specimen: report of two cases and review of the literature. Langenbeck's archives of surgery, 383(6), 447–452. https://doi.org/10.1007/s004230050158
- Storey, R. E., Huerighta, A. L., Khan, A., & Laber, D. A. (2011). spontaneous complete regression of hepatocellular carcinoma. Medical oncology (Norighthwood, London, England), 28(4), 948–950. https://doi.org/10.1007/s12032-010-9562-8
- Takeda, Y., Togashi, H., Shinzawa, H., Miyano, S., Ishii, R., Karasawa, T., Takeda, Y., Saito, T., Saito, K., Haga, H., Matsuo, T., Aoki, M., Mitsuhashi, H., Watanabe, H., & Takahashi, T. (2000). spontaneous regression of hepatocellular carcinoma and review of literature. Journal of gastroenterology and hepatology, 15(9), 1079–1086. https://doi.org/10.1046/j.1440-1746.2000.02202.x
- Tsai, S. C., Kao, J. L., & Shiao, C. C. (2014). spontaneous regression of a hepatoma with ring calcification. Acta clinica Belgica, 69(2), 130–131. https://doi.org/10.1179/2295333714Y.0000000011
- Ushigome, H., Koshino, K., Sakai, K., Suzuki, T., Nobori, S., Matsuyama, M., Okajima, H., Okamoto, M., & Yoshimura, N. (2011). Rare spontaneous remission of hepatic artery aneurysm following ABO incompatible living donor liver transplantation: a case report. Transplantation proceedings, 43(6), 2424–2427. https://doi.org/10.1016/j.transproceed.2011.05.036
- Kogiso, T., Hashimoto, E., Ikarashi, Y., Kodama, K., Taniai, M., Torii, N., Egawa, H., Yamamoto, M., & Tokushige, K. (2015). spontaneous clearance of HCV accompanying hepatitis after liver transplantation. Clinical journal of gastroenterology, 8(5), 323–329. https://doi.org/10.1007/s12328-015-0602-y
- L'Huillier, R., Milot, L., & Dumortier, J. (2024). Spontaneous Regression of Hepatocellular Carcinoma. Journal of gastrointestinal and liver diseases : JGLD, 33(3), 307. https://doi.org/10.15403/jgld-5469
- Franses, J. W., Bhan, I., Pankaj, A., Ting, D. T., Deshpande, V., & Tanabe, K. (2021). Spontaneous Immune-Mediated Regression of Hepatocellular Carcinoma With High Tumor Mutational Burden. JCO precision oncology, 5, PO.21.00092. https://doi.org/10.1200/PO.21.00092
- Ghattu, M., Engstrom, B. I., & Hanouneh, I. A. (2022). Spontaneous regression of hepatocellular carcinoma: what three cases of regression and disease reoccurrence can tell US. Radiology case reports, 17(9), 3405–3409. https://doi.org/10.1016/j.radcr.2022.06.086
- Costa-Santos, M. P., Gonçalves, A., Ferreira, A. O., & Nunes, J. (2020). Spontaneous regression of hepatocellular carcinoma: myth or reality?. BMJ case reports, 13(2), e233509. https://doi.org/10.1136/bcr-2019-233509
- Sonbare, D. J., Bandi, R., Sharma, V., Cacciarelli, T., & Shaikh, O. S. (2020). Spontaneous Regression of Advanced Hepatocellular Carcinoma. Case reports in gastroenterology, 14(3), 491–496. https://doi.org/10.1159/000508847
- Singh K. (2022). Spontaneous Regression of Hepatocellular Carcinoma From Autoinfarction and Implications on Liver Transplantation. ACG case reports journal, 9(7), e00825. https://doi.org/10.14309/crj.0000000000000825
- Xu, Y., Bayewitz, A., & Tary-Lehmann, M. (2023). Rapid Dissemination followed by Spontaneous Regression of Metastatic Hepatocellular Carcinoma after Liver Radiofrequency Thermal Ablation: A Case Report with Correlative Immune Assay. Case reports in oncology, 16(1), 129–136. https://doi.org/10.1159/000527229
- Kimura, T., Goi, T., Yokoi, S., Ohnishi, K., Togawa, T., Iida, A., Ishida, M., & Sato, Y. (2021). Possible spontaneous regression of hepatocellular carcinoma with unique histopathological features confirmed by surgical resection: a case report. Surgical case reports, 7(1), 162. https://doi.org/10.1186/s40792-021-01246-z
- Kawaguchi, T., Nakano, D., Okamura, S., Shimose, S., Hayakawa, M., Niizeki, T., Koga, H., & Torimura, T. (2019). Spontaneous regression of hepatocellular carcinoma with reduction in angiogenesis-related cytokines after treatment with sodium-glucose cotransporter 2 inhibitor in a cirrhotic patient with diabetes mellitus. Hepatology research : the official journal of the Japan Society of Hepatology, 49(4), 479–486. https://doi.org/10.1111/hepr.13247
- Koya, Y., Suzuki, T., Tai, M., Ichii, O., Matsuhashi, N., Ejiri, Y., Shibata, M., & Harada, M. (2018). Spontaneous Regression of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. Case reports in gastroenterology, 12(2), 411–419. https://doi.org/10.1159/000490661
- Hirata, T., Endo, S., Shirane, N., Kawaguchi, S., & Ohno, K. (2025). Unexpected Spontaneous Regression of Extensively Diffused Hepatocellular Carcinoma. Cureus, 17(2), e79366. https://doi.org/10.7759/cureus.79366
- Chohan, M. B. Y., Taylor, N., Coffin, C., Burak, K. W., & Bathe, O. F. (2019). Spontaneous Regression of Hepatocellular Carcinoma and Review of Reports in the Published English Literature. Case reports in medicine, 2019, 9756758. https://doi.org/10.1155/2019/9756758
- Ishii-Kitano, N., Enomoto, H., Nishimura, T., Aizawa, N., Shibata, Y., Higashiura, A., Takashima, T., Ikeda, N., Yuri, Y., Fujiwara, A., Yoshihara, K., Yoshioka, R., Kawata, S., Ota, S., Nakano, R., Shiomi, H., Hirota, S., Kumabe, T., Nakashima, O., & Iijima, H. (2022). Multiple Inflammatory Pseudotumors of the Liver Demonstrating Spontaneous Regression: A Case Report. Life (Basel, Switzerland), 12(1), 124. https://doi.org/10.3390/life12010124
- Shishimoto, T., Oura, S., Motozato, K., Tanaka, H., Takamatsu, S., & Ono, W. (2023). Epithelioid Hemangioendothelioma of the Liver Showing Spontaneous Complete Regression after the Cessation of Methotrexate Intake. Case reports in oncology, 16(1), 628–633. https://doi.org/10.1159/000531133
- Oshima, S., Inano, S., Honjo, G., Tabata, S., Fujimoto, M., Haga, H., & Kitano, T. (2025). Spontaneous Regression of Adult Multi-system Langerhans Cell Histiocytosis Presenting as Liver Tumor Rupture. Internal medicine (Tokyo, Japan), 64(8), 1217–1222. https://doi.org/10.2169/internalmedicine.4060-24
- Meares, A. 1979. Regression of Cancer of the Rectum After Intensive Meditation. Medical Journal of Australia 2: Nov 17 1979; 539-540
- Andrén & Frieberg, 1956. Spontaneous Regression of Polyps of the Colon in Children. Acta Radiologica 46: 1956; 507-510
- Gottfried et al., 1982. Spontaneous Regression of Hepatocellular Carcinoma. Gastroenterology 82(4): Apr 1982; 770-774
- Lam et al., 1982. Spontaneous Regression of Hepatocellular Carcinoma: A Case Study. Cancer 50(2): July 15 1982; 332-336
- Sato et al., 1985. A Case of Spontaneous Regression of Hepatocellular Carcinoma with Bone Metastasis. Cancer 56(3): Aug 1 1985; 667-671
- Ayres et al., 1990. Spontaneous Regression of Hepatocellular Carcinoma. Gut 31(6): Jun 1990; 722-724
- Morley, J. 1947. Carcinoma of the Ampulla of Vater. British Journal of Surgery 35: 1947; 146-151
- Mcsweeney et al., 1973. Spontaneous Regression of a Putative Childhood Hepatoma: A Reappraisal. American Journal of Diseases of Children 125(4): April 1973; 596-598
- Pardes et al., 1982. Spontaneous Regression of Infantile Hemangioendotheliomatosis of the Liver; Demonstration by Ultrasound. Journal of Ultrasound in Medicine 1(9): Nov-Dec 1982; 349-353
- Penkava & Rothenberg, 1981. Spontaneous Resolution of Oral ContraceptiveAssociated Liver Tumor. Journal of Computer Assisted Tomography 5(1): 1981; 102-103
- Buhler et al., 1982. Regression of Liver Cell Adenoma:; A Follow-Up Study of Three Consecutive Patients After Discontinuation of Oral Contraceptive Use. Gastroenterology 82(4): Apr 1982; 775-782
- Abiru, S., Kato, Y., Hamasaki, K., Nakao, K., Nakata, K., & Eguchi, K. (2002). Spontaneous regression of hepatocellular carcinoma associated with elevated levels of interleukin 18. The American Journal of Gastroenterology, 97(3), 774-775. doi:10.1111/j.1572-0241.2002.05580.x
- Heianna, J., Miyauchi, T., Suzuki, T., Ishida, H., Hashimoto, M., & Watarai, J. (2007). Spontaneous regression of multiple lung metastases following regression of hepatocellular carcinoma after transcatheter arterial embolization. A case report. Hepato-Gastroenterology, 54(77), 1560-1562.
- Herreros-Villanueva, M., Hijona, E., Cosme, A., & Bujanda, L. (2012). Spontaneous regression of pancreatic cancer: Real or a misdiagnosis? World Journal of Gastroenterology : WJG, 18(23), 2902-2908. doi:10.3748/wjg.v18.i23.2902
- Hirakawa, H., Ueno, S., Matuda, H., Hinoki, T., & Kato, Y. (2009). Telangiectatic focal nodular hyperplasia of the liver in an infant with spontaneous regression: A case report. The Tokai Journal of Experimental and Clinical Medicine, 34(1), 25-27.
- Jeon, S. W., Lee, M. K., Lee, Y. D., Seo, H. E., Cho, C. M., Tak, W. Y., & Kweon, Y. O. (2005). Clear cell hepatocellular carcinoma with spontaneous regression of primary and metastatic lesions. The Korean Journal of Internal Medicine, 20(3), 268-273.
- Rizell, M., Cahlin, C., Friman, S., Hafstrom, L., Lonn, L., Olausson, M., & Lindner, P. (2005). Impressive regression of primary liver cancer after treatment with sirolimus. Acta Oncologica (Stockholm, Sweden), 44(5), 496. doi:10.1080/02841860510044610
- Vardhana, H. G., & Panda, M. (2007). Spontaneous regression of hepatocellular carcinoma: Potential promise for the future. Southern Medical Journal, 100(2), 223-224.
- Parks AL, McWhirter RM, Evason K, Kelley RK.. Cases of spontaneous tumor regression in hepatobiliary cancers: implications for immunotherapy?
- Sawada Y; Iwamoto S; Yurino N; Fujii S; Murai N; Okuno F; Kotake H; Mashiba H. Rupture of Hepatocellular Carcinoma with Multiple Pulmonary Metastasis Successfully Treated by Transcatheter Arterial Embolization (TAE) of tumour: A Case Report
- Choi, C. S., Cho, E. Y., Jeong, J. S., Im, C. J., Yang, B. J., & Kim, H. C. (2010). Spontaneous regression of a solitary necrotic nodule of the liver. Hepatology International, 4(3), 649-652. doi:10.1007/s12072-010-9199-x
- Iijima, H., Moriwaki, Y., Yamamoto, T., Takahashi, S., Nishigami, T., & Hada, T. (2001). Spontaneous regression of hepatic adenoma in a patient with glycogen storage disease type I after hemodialysis: Ultrasonographic and CT findings. Internal Medicine (Tokyo, Japan), 40(9), 891-895.
- Inui, A., Fujisawa, T., Kubo, T., Sogo, T., Komatsu, H., & Kagata, Y. (2005). A case of neonatal hemochromatosis-like liver failure with spontaneous remission. Journal of Pediatric Gastroenterology and Nutrition, 40(3), 374-377.
- Jerraya, H., Jarboui, S., Daghmoura, H., & Zaouche, A. (2011). A new case of spontaneous regression of inflammatory hepatic pseudotumor. Case Reports in Medicine, 2011, 139125. doi:10.1155/2011/139125
- Laumonier, H., Leblanc, F., Balabaud, C., & Bioulac-Sage, P. (2010). Spontaneous regression of focal nodular hyperplasia: A pathological report. BMJ Case Reports, 2010, 10.1136/bcr.02.2010.2704. doi:10.1136/bcr.02.2010.2704;
- Levy, S., Sauvanet, A., Diebold, M. D., Marcus, C., Da Costa, N., & Thiefin, G. (2001). Spontaneous regression of an inflammatory pseudotumor of the liver presenting as an obstructing malignant biliary tumor. Gastrointestinal Endoscopy, 53(3), 371-374.
- Pohl, J., Hess, T., Hofmann, W., Stremmel, W., & Kallinowski, B. (2000). Spontaneous regression of intrahepatic lesions mimicking metastatic disease. Zeitschrift Fur Gastroenterologie, 38(9), 803-806. doi:10.1055/s-2000-10944
- Volkmann, X., Anstaett, M., Hadem, J., Stiefel, P., Bahr, M. J., Lehner, F., . . . Bantel, H. (2008). Caspase activation is associated with spontaneous recovery from acute liver failure. Hepatology (Baltimore, Md.), 47(5), 1624-1633. doi:10.1002/hep.22237
- Huz, J. I., Melis, M., & Sarpel, U. (2012). Spontaneous regression of hepatocellular carcinoma is most often associated with tumour hypoxia or a systemic inflammatory response. HPB : The Official Journal of the International Hepato Pancreato Biliary Association, 14(8), 500-505. doi:10.1111/j.1477-2574.2012.00478.x;
- Hsiao, Y. W., Liao, K. W., Chung, T. F., Liu, C. H., Hsu, C. D., & Chu, R. M. (2008). Interactions of host IL-6 and IFN-gamma and cancer-derived TGF-beta1 on MHC molecule expression during tumor spontaneous regression. Cancer Immunology, Immunotherapy : CII, 57(7), 1091-1104. doi:10.1007/s00262-007-0446-5
- Tovo, C. V. 2024. Spontaneous regression of hepatocellular carcinoma: focusing in the associated risk factors
- (2009). European Journal of Gastroenterology & Hepatology, 21(3), 254-257